MEDP
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.
Medpace Holdings, Inc. (MEDP) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.
Quantitative Factor Evaluation • Updated
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Subscribe to unlock
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-16 | C+ (2.5) | C (2.2) | B (3.5) | B+ (3.8) | B+ (3.6) | B- (3.1) |
| 2026-11-09 | C (2.4) | C (2.2) | B (3.5) | B+ (3.6) | B+ (3.6) | B- (3.1) |
| 2026-11-05 | C+ (2.5) | C- (2.1) | B (3.4) | B+ (3.7) | B+ (3.6) | B- (3.1) |
| 2026-11-02 | C+ (2.5) | C- (2.1) | B (3.4) | B+ (3.6) | B+ (3.8) | B- (3.1) |
| 2026-10-27 | C+ (2.5) | C- (2.1) | B (3.4) | B+ (3.6) | A (4.3) | B (3.2) |
Showing the last month only. Subscribe for the full factor score history.
For more — Subscribe